VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage ; volume:13 ; number:1 ; day:29 ; month:6 ; year:2016 ; pages:1-14 ; date:12.2016
Journal of neuroinflammation ; 13, Heft 1 (29.6.2016), 1-14, 12.2016
- Creator
-
Abad, Catalina
- Contributor
-
Jayaram, Bhavaani
Becquet, Laurine
Wang, Yuki
O’Dorisio, M Sue
Waschek, James A.
Tan, Yossan-Var
SpringerLink (Online service)
- DOI
-
10.1186/s12974-016-0626-3
- URN
-
urn:nbn:de:1111-201607019830
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abad, Catalina
- Jayaram, Bhavaani
- Becquet, Laurine
- Wang, Yuki
- O’Dorisio, M Sue
- Waschek, James A.
- Tan, Yossan-Var
- SpringerLink (Online service)
Other Objects (12)
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs
Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats
Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection
Ginsenoside ameliorated ventilator-induced lung injury in rats
Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
Über postvaccinale Encephalomyelitis
Encephalomyelitis by adenovirus
Exhibit 183
Exhibit 25
Exhibit 195
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs
Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats
Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection
Ginsenoside ameliorated ventilator-induced lung injury in rats
Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
Über postvaccinale Encephalomyelitis
Encephalomyelitis by adenovirus
Exhibit 183
Exhibit 25
Exhibit 195
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs
Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats
Polyphenolic Platform Ameliorated Sanshool for Skin Photoprotection
Ginsenoside ameliorated ventilator-induced lung injury in rats
Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
Über postvaccinale Encephalomyelitis
Encephalomyelitis by adenovirus
Exhibit 183
Exhibit 25